Skip to main content
Log in

Plasma concentrations of propranolol in patients with essential hypertension

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

Sixteen patients with essential hypertension were treated with propranolol 160 to 640 mg daily for three months. Significant decreases both in recumbent and standing blood pressure were observed after three days treatment and subsequently. Reduction of blood pressure was more pronounced when the dose of propranolol was increased. However, neither the mean dose nor the plasma concentration of propranolol could be correlated with the mean decrease in blood pressure. There was great interindividual variation in the plasma concentrations of propranolol produced by the same daily dose. The initial stimulation of plasma renin activity and the therapeutic response to propranolol could not be correlated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Berglund, G., Andersson, O., Hansson, L., Olander, R.: Propranolol given twice daily in hypertension. Acta med. scand.194, 513–515 (1973)

    Google Scholar 

  • Bühler, F. R., Laragh, J. H., Vaughan, E. D., Brunner, H. R., Gavras, H., Baer, L.: Antihypertensive action of propranolol. Amer. J. Cardiol.32, 511–522 (1973)

    Google Scholar 

  • Chidsey, C. A., Morselli, P., Bianchetti, G., Morganti, A., Leonetti, G., Zanchetti, A.: Studies of the absorption and removal of propranolol in hypertensive patients during therapy. Circulation52, 313–318 (1975)

    Google Scholar 

  • Hansson, L., Zweifler, A. J., Julius, S., Ellis, C. N.: Propranolol therapy in essential hypertension. Observations on predictability of therapeutic response. Int. J. clin. Pharmacol.10, 79–89 (1974)

    Google Scholar 

  • Koch-Weser, J., Sellers, E. M.: Binding of drugs to serum albumin. New Engl. J. Med.294, 311–316 (1976)

    Google Scholar 

  • Nies, A. S., Shand, D. G.: Clinical pharmacology of propranolol. Circulation52, 6–15 (1975)

    Google Scholar 

  • Prichard, B. N. C., Gillam, P. M. S.: Treatment of hypertension with propranolol Brit. med. J.1969 I, 7–16

    Google Scholar 

  • Shand, D. G., Nuckolls, E. M., Oates, J. A.: Plasma propranolol levels in adults with observations in four children. Clin. Pharmacol. Ther.11, 112–120 (1970)

    Google Scholar 

  • Shand, D. G.: Individualization of propranolol therapy. Med. Clin. North. Amer.58, 1063–1069 (1974)

    Google Scholar 

  • Shand, D. G.: Propranolol. New Engl. J. med.293, 280–285 (1975)

    Google Scholar 

  • Stokes, G. S., Weber, M. A., Thornell, J. R.: Betablockers and plasma renin activity in hypertension. Brit. med. J.1971 I, 60–62

    Google Scholar 

  • Wallach, L., Nyarai, I., Dawson, K. G.: Stimulated renin: A screening test for hypertension. Ann. int. Med.82, 27–34 (1975)

    Google Scholar 

  • Zacharias, F. J., Cowen, K. J., Vickers, B. G.: Propranolol in hypertension: a study of long-term therapy 1964–1970. Amer. Heart J.83, 755–761 (1972)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lehtonen, A., Kanto, J. & Kleimola, T. Plasma concentrations of propranolol in patients with essential hypertension. Eur J Clin Pharmacol 11, 155–157 (1977). https://doi.org/10.1007/BF00606403

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00606403

Key words

Navigation